Aberrant neuronal and mitochondrial proteins in hippocampus of transgenic mice overexpressing human Cu/Zn superoxide dismutase 1

Free Radical Biology and Medicine

Volumn 37, Issue 5, 2004, Pages 643-653

  Shin, Joo Ho ^a   London, Jacqueline ^b   Le Pecheur, Marie ^b   Höger, Harald ^c   Pollak, Daniela ^a   Lubec, Gert ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Institute of Animal Genetics   (Austria)

Author keywords

2 DE; ATP; ATP synthase; Cu Zn superoxide dismutase 1; Down syndrome; DS; DYN1; dynamin 1; EFTU; Free radicals; Hippocampus; Mitochondrial protein; Neuronal proteins; Transgenic mice; Two dimensional gel electrophoresis; two dimensional gel electrophoresis

Indexed keywords

BRAIN PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; DYNAMIN I; ELONGATION FACTOR TU; MITOCHONDRIAL PROTEIN; N ETHYLMALEIMIDE; NEUROFILAMENT PROTEIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNTAXIN; TROPOMODULIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHROMOSOME 21; CONTROLLED STUDY; DOWN SYNDROME; GEL ELECTROPHORESIS; HEMIZYGOSITY; HIPPOCAMPUS; HOMOZYGOSITY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNAPTOSOME; WILD TYPE;

ANIMALS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HIPPOCAMPUS; HUMANS; MICE; MICE, TRANSGENIC; MITOCHONDRIA; MITOCHONDRIAL SWELLING; NERVE TISSUE PROTEINS; NEURONS; RESTRICTION MAPPING; SUPEROXIDE DISMUTASE;

MUS MUSCULUS;

EID: 3342931462     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2004.05.019     Document Type: Article

References (40)

1. Groner Y., Lieman-Hurwitz J., Dafni N., Sherman L., Levanon D., Bernstein Y., Danciger E., Elroy-Stein O. Molecular structure and expression of the gene locus on chromosome 21 encoding the Cu/Zn superoxide dismutase and its relevance to Down syndrome. Ann. NY Acad. Sci. 450:1985;133-156
2. Gulesserian T., Seidl R., Hardmeier R., Cairns N., Lubec G. Superoxide dismutase SOD1, encoded on chromosome 21, but not SOD2 is overexpressed in brains patients with Down syndrome. J. Invest. Med. 49:2001;41-46
3. Epstein C.J., Avraham K.B., Lovett M., Smith S., Elroy-Stein O., Rotman G., Bry C., Groner Y. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proc. Natl. Acad. Sci. USA. 84:1987;8044-8048
4. Avraham K.B., Sugarman H., Rotshenker S., Groner Y. Down's syndrome: morphological remodelling and increased complexity in the neuromuscular junction of transgenic CuZn-superoxide dismutase mice. J. Neurocytol. 20:1991;208-215
5. Gahtan E., Auerbach J.M., Groner Y., Segal M. Reversible impairment of long-term potentiation in transgenic Cu/Zn-SOD mice. Eur. J. Neurosci. 10:1998;538-544
6. Nabarra B., Casanova M., Paris D., Nicole A., Toyama K., Sinet P.M., Ceballos I., London J. Transgenic mice overexpressing the human Cu/Zn-SOD gene: ultrastructural studies of a premature thymic involution model of Down's syndrome (trisomy 21). Lab. Invest. 74:1996;617-626
7. Schickler M., Knobler H., Avraham K.B., Elroy-Stein O., Groner Y. Diminished serotonin uptake in platelets of transgenic mice with increased Cu/Zn-superoxide dismutase activity. EMBO J. 8:1989;1385-1392
8. Jaarsma D., Haasdijk E.D., Grashorn J.A., Hawkins R., van Duijn W., Verspaget H.W., London J., Holstege J.C. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1. Neurobiol. Dis. 7:2000;623-643
9. Paris D., Toyama K., Mégarbané A., Casanova M., Sinet P.M., London J. Rapid fluorescence in situ hybridization on interphasic nuclei to discriminate between homozygous and heterozygous transgenic mice. Transgenic Res. 5:1996;397-403
10. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 344:1976;125-132
11. Weitzdoerfer R., Fountoulakis M., Lubec G. Reduction of actin-related protein complex 2/3 in fetal Down syndrome brain. Biochem. Biophys. Res. Commun. 293:2002;836-841
12. Langen H., Berndt P., Roder D., Cairns N., Lubec G., Fountoulakis M. Two-dimensional map of human brain proteins. Electrophoresis. 20:1999;907-916
13. Suckau D., Resemann A., Schuerenberg M., Hufnagel P., Franzen J., Holle A. A novel MALDI LIFT-TOF/TOF mass spectrometer for proteomics. Anal. Bioanal. Chem. 376:2003;952-965
14. Sudhof T.C., De Camilli P., Niemann H., Jahn R. Membrane fusion machinery: insights from synaptic proteins. Cell. 75:1993;1-4
15. Bennett M.K., Scheller R.H. The molecular machinery for secretion is conserved from yeast to neurons. Proc. Natl. Acad. Sci. USA. 90:1993;2559-2563
16. Sollner T., Whiteheart S.W., Brunner M., Erdjument-Bromage H., Geromanos S., Tempst P., Rothman J.E. SNAP receptors implicated in vesicle targeting and fusion. Nature. 362:1993;318-324
17. Trimble W.S., Cowan D.M., Scheller R.H. VAMP-1: a synaptic vesicle-associated integral membrane protein. Proc. Natl. Acad. Sci. USA. 85:1988;4538-4542
18. Baumert M., Maycox P.R., Navone F., De Camilli P., Jahn R. Synaptobrevin: an integral membrane protein of 18,000 daltons present in small synaptic vesicles of rat brain. EMBO J. 8:1989;379-384
19. Bennett M.K., Calakos N., Scheller R.H. Syntaxin: a synaptic protein implicated in docking of synaptic vesicles at presynaptic active zones. Science. 257:1992;255-259
20. Oyler G.A., Higgins G.A., Hart R.A., Battenberg E., Billingsley M., Bloom F.E., Wilson M.C. The identification of a novel synaptosomal-associated protein, SNAP-25, differentially expressed by neuronal subpopulations. J. Cell Biol. 109:1989;3039-3052
21. Rizo J., Südhof T.C. SNAREs and Munc18 in synaptic vesicle fusion. Nat. Rev. 3:2002;641-653
22. Hanson P.I., Otto H., Barton N., Jahn R. The N-ethylmaleimide-sensitive fusion protein and alpha-SNAP induce a conformational change in syntaxin. J. Biol. Chem. 270:1995;16955-16961
23. Pevsner J., Hsu S.C., Scheller R.H. n-Sec1: a neural-specific syntaxin-binding protein. Proc. Natl. Acad. Sci. USA. 91:1994;1445-1449
24. Misura K.M., Scheller R.H., Weis W.I. Three-dimensional structure of the neuronal-Sec1-syntaxin 1a complex. Nature. 404:2000;355-362
25. Yang B., Steegmaier M., Gonzalez L.C. Jr., Scheller R.H. nSec1 binds a closed conformation of syntaxin1A. J. Cell Biol. 148:2000;247-252
26. Sudhof T.C., Czernik A.J., Kao H.T., Takei K., Johnston P.A., Horiuchi A., Kanazir S.D., Wagner M.A., Perin M.S., De Camilli P., et al. Synapsins: mosaics of shared and individual domains in a family of synaptic vesicle phosphoproteins. Science. 245:1989;1474-1480
27. Robinson P.J., Liu J.P., Powell K.A., Fykse E.M., Sudhof T.C. Phosphorylation of dynamin I and synaptic-vesicle recycling. Trends Neurosci. 17:1994;348-353
28. Vickers J.C., Costa M. The neurofilament triplet is present in distinct subpopulations of neurons in the central nervous system of the guinea-pig. Neuroscience. 49:1992;73-100
29. Bajo M., Yoo B.C., Cairns N., Gratzer M., Lubec G. Neurofilament proteins NF-L, NF-M and NF-H in brain of patients with Down syndrome and Alzheimer's disease. Amino Acids. 21:2001;293-301
30. Teipel S.J., Schapiro M.B., Alexander G.E., Krasuski J.S., Horwitz B., Hoehne C., Moller H.J., Rapoport S.I., Hampel H. Relation of corpus callosum and hippocampal size to age in nondemented adults with Down's syndrome. Am. J. Psychiatry. 160:2003;1870-1878
31. Head E., Lott I.T., Hof P.R., Bouras C., Su J.H., Kim R., Haier R., Cotman C.W. Parallel compensatory and pathological events associated with tau pathology in middle aged individuals with Down syndrome. J. Neuropathol. Exp. Neurol. 62:2003;917-926
32. Busciglio J., Yankner B.A. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature. 378:1995;776-779
33. Ceballos I., Nicole A., Briand P., Grimber G., Delacourte A., Flament S., Blouin J.L., Thevenin M., Kamoun P., Sinet P.M. Expression of human Cu-Zn superoxide dismutase gene in transgenic mice: model for gene dosage effect in Down syndrome. Free Radic. Res. Commun. 12/13(Pt 2):1991;581-589
34. Engidawork E., Lubec G. Molecular changes in fetal Down syndrome brain. J. Neurochem. 84:2003;895-904
35. Weitzdoerfer R., Dierssen M., Fountoulakis M., Lubec G. Fetal life in Down syndrome starts with normal neuronal density but impaired dendritic spines and synaptosomal structure. J. Neural. Transm. Suppl. 61:2001;59-70
36. Greber S., Lubec G., Cairns N., Fountoulakis M. Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease. Electrophoresis. 20:1999;928-934
37. Kim S.H., Fountoulakis M., Dierssen M., Lubec G. Decreased protein levels of complex I 30-kDa subunit in fetal Down syndrome brains. J. Neural. Transm. Suppl. 61:2001;109-116
38. Kim S.H., Vlkolinsky R., Cairns N., Fountoulakis M., Lubec G. The reduction of NADH ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's disease. Life Sci. 68:2001;2741-2750
39. Chotiner J.K., Khorasani H., Nairn A.C., O'Dell T.J., Watson J.B. Adenylyl cyclase-dependent form of chemical long-term potentiation triggers translational regulation at the elongation step. Neuroscience. 116:2003;743-752
40. Freidl M., Gulesserian T., Lubec G., Fountoulakis M., Lubec B. Deterioration of the transcriptional, splicing and elongation machinery in brain of fetal Down syndrome. J. Neural. Transm. Suppl. 61:2001;47-57